John Huemoeller, Chief Executive Officer at AXIM Biotechnologies

John Huemoeller

Chief Executive Officer at AXIM Biotechnologies | San Diego, California, United States

Profile last verified August 2026
Biotechnology Research Verified Profile San Diego, California, United States
Verified

Work Email

***@aximbiotech.com

Last verified September 2026

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

+17*****

United States • Mobile

Free account · No credit card · 5 profiles/month

John Huemoeller Socials
John Huemoeller Work Experience

Chief Executive Officer at AXIM Biotechnologies

John Huemoeller Skills
Presentation Skills Strategic Partnerships Cancer Relationship Development Sales Processes Request for Proposal (RFP) Negotiation Microsoft Office Leadership Investments Marketing Sales Creative Strategy Operations Management Financial Analysis Marketing Strategy Contract Negotiation Commerce Angel Investing Business Development Start-up Ventures Board of Directors
About John Huemoeller’s Current Company
AXIM Biotechnologies

AXIM Biotechnologies is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical, and cosmetic products as well as alternative energy sources. We prioritize the well-being of our customers while embracing a solid fiscal strategy. We believe in setting the green standard for cannabinoid bioscience through the discovery and commercialization of new materials and technologies for healthy living while respecting the environment. Public Relations Contact Andrew Hard Chief Executive Officer CMW Media [email protected] P. +1888 829-0070 www.cmwmedia.com Investor Relations Contact Shiwei Yin, Grayling [email protected] P. +1646 824-2857 Lucia Domville, Grayling [email protected] P. +1646 284-9416

Discover more about AXIM Biotechnologies
John Huemoeller’s Colleagues
Laura Periman

Laura Periman

Seattle, Washington, United States

Founder and Director of Dry Eye Services and Clinical Research at Periman Eye Institute

Periman Eye Institute provides world class expert diagnosis, treatment and integrated care for Ocular Surface Diseases such as Dry Eye Disease and MGD.

Our robust Clinical Research program includes phase 2, phase 3 and phase 4 clinical trials.

Jeffrey Busby

Jeffrey Busby

United States

Axim Biotechnologies, Inc.

Sr. Vice President Global Sales at AXIM Biotechnologies
(Jan 2025 – Present)

Search similar profiles
Frequently asked questions about John Huemoeller

What company does John Huemoeller work for?

John Huemoeller works for AXIM Biotechnologies.

What is John Huemoeller's role at AXIM Biotechnologies?

John Huemoeller is Chief Executive Officer

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free